Patent details

301120 Product Name: dostarlimab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301120
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2992017
Status:
SPC granted but not yet in force
Application number:
301120
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/21/1538
Marketing Authorization Type:
EEA
Marketing Authorization Date:
22/04/2021
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
11/08/2021
First Marketing Authorization date:
22/04/2021
Grant date:
15/11/2021
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
11/08/2021
SPC/SPC Extension Expiration Date:
21/04/2036
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
11/08/2021
 
 

 

Name:
AnaptysBio, Inc.
Address:
10770 Wateridge Circle, Suite 210, 92121, San Diego, CA, United States of America (US)

Agent

Name:
ir. F.A. Geurts c.s.
From:
11/08/2021
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
46/21
Publication date:
17/11/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
33/21
Publication date:
18/08/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
31/05/2034
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
15/11/2021 Outgoing Correspondence Decision grant 1 PDF /2/0/7/3/1/0800713702/docs/301120_1_446042l504a.pdf
15/11/2021 Certificate Certificate 1 PDF /2/0/7/3/1/0800713702/docs/301120_4_spcmedcertificate20211115114655171.pdf
12/08/2021 Outgoing Correspondence Confirmation receipt request 1 PDF /2/0/7/3/1/0800713702/docs/301120_5_428800l174.pdf
11/08/2021 Application Form First filed application form 4 PDF /2/0/7/3/1/0800713702/docs/301120_0_applicationform20210811033600156.pdf
11/08/2021 SPC Documents Annex SPC 2 PDF /2/0/7/3/1/0800713702/docs/301120_2_supplprotectioncertificate20210811034248333.pdf
11/08/2021 SPC Documents Summary of the characteristics of the product 18 PDF /2/0/7/3/1/0800713702/docs/301120_3_supplprotectioncertificate20210811034503079.pdf
11/08/2021 SPC Documents Marketing Authorization SPC 3 PDF /2/0/7/3/1/0800713702/docs/301120_6_supplprotectioncertificate20210811034045672.pdf
11/08/2021 SPC Documents Annex SPC 2 PDF /2/0/7/3/1/0800713702/docs/301120_7_supplprotectioncertificate20210811034127722.pdf
11/08/2021 SPC Documents Annex SPC 1 PDF /2/0/7/3/1/0800713702/docs/301120_8_supplprotectioncertificate20210811034212009.pdf